US › Healthcare

Hepion Pharmaceuticals Inc (HEPA)

US · Healthcare · Biotechnology

$0.06-3.48%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Revenue YoY

-100.0%

Net profit

$-810,791

Profit YoY

+86.7%

EPS

$-0.09

EPS estimate

$0.00

Key statistics

Market cap

$1.3M

P/E

0.0

Forward P/E

0.0

P/B

8.27

Book value

$0.01

EPS (TTM)

$1.20

52-week high

$0.11

52-week low

$0.03

50-day MA

$0.06

200-day MA

$0.06

Beta

1.63

Analyst view

Analysts rate Hepion Pharmaceuticals Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $30.00.

Shareholding

Insiders

38.64%

Largest institutional holders

Fund	Stake
XTX Topco Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Hepion Pharmaceuticals Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.